デフォルト表紙
市場調査レポート
商品コード
1611944

病理学におけるAI市場:コンポーネント、ニューラルネットワーク、アプリケーション、エンドユーザー別-2025-2030年の世界予測

AI in Pathology Market by Component (Hardware, Software), Neural Network (Convolutional neural networks (CNNs), Generative adversarial networks (GANs), Recurrent neural networks (RNNs)), Application, End-User - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 188 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.30円
病理学におけるAI市場:コンポーネント、ニューラルネットワーク、アプリケーション、エンドユーザー別-2025-2030年の世界予測
出版日: 2024年12月01日
発行: 360iResearch
ページ情報: 英文 188 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

病理学におけるAI市場は、2023年に2,901万米ドルと評価され、2024年には3,336万米ドルに達すると予測され、CAGR 15.33%で成長し、2030年には7,875万米ドルに達すると予測されています。

病理学における人工知能(AI)は、診断精度、効率性、個別化された患者ケアを強化することで、ヘルスケア業界に革命をもたらしています。この分野では、自動化および半自動化された病理学的評価のために、機械学習アルゴリズムと画像解析ツールを活用しています。病理学におけるAIの必要性は、診断手順の複雑化、ハイスループット・スクリーニングの需要、世界の病理医の不足から生じています。アプリケーションには、デジタル病理学、組織分析、疾患検出、予後評価などがあり、エンドユーザーには病院、診断研究所、研究機関などが含まれます。

主な市場の統計
基準年[2023] 2,901万米ドル
予測年[2024] 3,336万米ドル
予測年[2030] 7,875万米ドル
CAGR(%) 15.33%

市場の成長は、計算技術の進歩、ヘルスケアにおけるAI導入の増加、精密医療への注目の高まりによって促進されます。AI技術の統合は病気の早期発見を助け、ワークフローの効率を向上させ、需要を牽引します。しかし、データプライバシーに関する懸念、高い導入コスト、標準化された規制枠組みの欠如が大きな課題となっています。この分野は、正確なパターン認識や予測分析を容易にするディープラーニングやビッグデータ解析などの技術強化から利益を得ています。ヘルスケアのデジタル化とAI研究に投資する政府や民間団体は、市場の拡大をさらに活性化させる。

テーラーメイドのAIソリューションを開発するためのハイテク企業とヘルスケアプロバイダーとの共同事業には、新たな開発機会が眠っています。規制機関は、AIの導入を加速するために明確なガイドラインを策定することが奨励されます。市場は、より高い解釈可能性とリアルタイムの分析能力を備えたAIプラットフォームの開発において、技術革新の機が熟しています。しかし、相互運用性の問題や、患者ケアにおけるAIの意思決定に関する倫理的懸念などの課題を克服することは、依然として重要です。市場はダイナミックであり、人間の診断能力を凌駕するAIアルゴリズムの改良に焦点を当てた継続的な研究開発努力が行われているため、利害関係者には大きな投資収益が期待できます。様々なヘルスケアシステム間のデータ統合を強化するイノベーションの追求と、説明可能なAIの重視は、将来の成長と競争優位性のための有望な道筋を示しています。

市場力学:急速に進化する病理学におけるAI市場の主要市場インサイトを公開

病理学におけるAI市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 世界の病理学のデジタル化の進展
    • 慢性疾患の蔓延に伴うテレパソロジーのニーズの高まり
  • 市場抑制要因
    • 病理学におけるAIに関連する高コスト
  • 市場機会
    • 病理学におけるAIの技術的進歩
    • 個別化・カスタマイズ医療への需要の高まり
  • 市場の課題
    • データプライバシーに関する懸念

ポーターのファイブフォース:病理学におけるAI市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:病理学におけるAI市場における外部からの影響の把握

外部マクロ環境要因は、病理学におけるAI市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析病理学におけるAI市場における競合情勢の把握

病理学におけるAI市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス病理学におけるAI市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、病理学におけるAI市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨病理学におけるAI市場における成功への道筋を描く

病理学におけるAI市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中で病理学のデジタル化が進む
      • 慢性疾患の蔓延に伴うテレパソロジーの必要性の高まり
    • 抑制要因
      • 病理学におけるAIに関連する高コスト
    • 機会
      • 病理学におけるAIにおける技術的進歩
      • パーソナライズされたカスタマイズされた医療の需要の高まり
    • 課題
      • データプライバシーに関する懸念
  • 市場セグメンテーション分析
    • コンポーネント:シームレスなワークフローと効率的なデータ管理を実現する病理学における広範なソフトウェアアプリケーション
    • ニューラルネットワーク:診断の精度と効率性の向上により、生成的敵対ネットワークの採用が増加
    • 応用:病気の早期発見を促進するために、病気の診断に病理学におけるAIを広く活用する
    • エンドユーザー:潜在的な治療薬の発見のための製薬・バイオテクノロジー企業における病理学AIの拡大
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 病理学におけるAI市場:コンポーネント別

  • ハードウェア
  • ソフトウェア

第7章 病理学におけるAI市場ニューラルネットワーク

  • 畳み込みニューラルネットワーク(CNN)
  • 生成的敵対ネットワーク(GAN)
  • リカレントニューラルネットワーク(RNN)

第8章 病理学におけるAI市場:用途別

  • 臨床ワークフロー
  • 病気の診断と予後
  • 創薬
  • トレーニングと教育

第9章 病理学におけるAI市場:エンドユーザー別

  • 学術調査機関
  • 病院
  • 製薬・バイオテクノロジー企業

第10章 南北アメリカの病理学におけるAI市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の病理学におけるAI市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの病理学におけるAI市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
    • マイクロソフトが世界最大の病理学、腫瘍学画像AIの構築に協力
    • PathAIは、腫瘍微小環境から未開拓の洞察を引き出すAI搭載病理パネルPathExploreを発表
    • ペイジとライカバイオシステムズ、世界なデジタル病理学ワークフローにおける画像管理と人工知能技術の利用を強化するための提携拡大を発表
  • 戦略分析と提言

企業一覧

  • aetherAI
  • Aiforia Technologies Oyj
  • Akoya Biosciences, Inc.
  • Deep Bio, Inc.
  • Evident Corporation
  • F. Hoffmann-La Roche Ltd.
  • Ibex Medical Analytics Ltd.
  • Indica Labs, Inc.
  • Inspirata, Inc.
  • LUMEA, Inc.
  • MindPeak GmbH
  • Nucleai Inc.
  • OptraSCAN Inc.
  • Paige.AI, Inc.
  • PathAI, Inc.
  • Proscia Inc.
  • Techcyte, Inc.
  • Tempus Labs, Inc.
  • Tribun Health
  • Visikol, Inc. by CELLINK
  • Visiopharm A/S
図表

LIST OF FIGURES

  • FIGURE 1. AI IN PATHOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. AI IN PATHOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL AI IN PATHOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. AI IN PATHOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. AI IN PATHOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. AI IN PATHOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL AI IN PATHOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. AI IN PATHOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORKS (CNNS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY GENERATIVE ADVERSARIAL NETWORKS (GANS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY RECURRENT NEURAL NETWORKS (RNNS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY CLINICAL WORKFLOW, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS & PROGNOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. AI IN PATHOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. AI IN PATHOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-1730A405FA4B

The AI in Pathology Market was valued at USD 29.01 million in 2023, expected to reach USD 33.36 million in 2024, and is projected to grow at a CAGR of 15.33%, to USD 78.75 million by 2030.

Artificial Intelligence (AI) in pathology is revolutionizing the healthcare industry by enhancing diagnostic accuracy, efficiency, and personalized patient care. The field involves leveraging machine learning algorithms and image analysis tools for automated and semi-automated pathological assessments. The necessity of AI in pathology arises from the increasing complexity of diagnostic procedures, the demand for high-throughput screening, and the global shortage of trained pathologists. Applications encompass digital pathology, tissue analysis, disease detection, and prognosis assessment, with end-users including hospitals, diagnostic laboratories, and research institutions.

KEY MARKET STATISTICS
Base Year [2023] USD 29.01 million
Estimated Year [2024] USD 33.36 million
Forecast Year [2030] USD 78.75 million
CAGR (%) 15.33%

Market growth is propelled by advancements in computational technologies, increasing adoption of AI in healthcare, and a growing focus on precision medicine. The integration of AI technologies aids in early disease detection and improves workflow efficiency, driving demand. However, data privacy concerns, high implementation costs, and lack of standardized regulatory frameworks pose significant challenges. The sector benefits from technological enhancements such as deep learning and big data analytics, which facilitate precise pattern recognition and predictive analytics. Governments and private entities investing in healthcare digitization and AI research further energize market expansion.

Emerging opportunities lie in collaborative ventures between tech companies and healthcare providers to develop tailored AI solutions. Regulatory bodies are encouraged to establish clear guidelines to accelerate AI adoption. The market is ripe for innovation in developing AI platforms with higher interpretability and real-time analytical capabilities. However, overcoming challenges such as interoperability issues and ethical concerns regarding AI decision-making in patient care remains critical. The market is dynamic, with continuous R&D efforts focused on refining AI algorithms to surpass human diagnostic capabilities, thus ensuring significant returns on investment for stakeholders. The pursuit of innovations that enhance data integration across various healthcare systems and the emphasis on explainable AI represent promising avenues for future growth and competitive advantage.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving AI in Pathology Market

The AI in Pathology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing digitalization of pathology worldwide
    • Growing need for telepathology with the prevalence of chronic disease
  • Market Restraints
    • High cost associated with AI in pathology
  • Market Opportunities
    • Technological advancements in AI in pathology
    • Rising demand for personalized and customized medicine
  • Market Challenges
    • Concerns associated with data privacy

Porter's Five Forces: A Strategic Tool for Navigating the AI in Pathology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the AI in Pathology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the AI in Pathology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the AI in Pathology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the AI in Pathology Market

A detailed market share analysis in the AI in Pathology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the AI in Pathology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the AI in Pathology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the AI in Pathology Market

A strategic analysis of the AI in Pathology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the AI in Pathology Market, highlighting leading vendors and their innovative profiles. These include aetherAI, Aiforia Technologies Oyj, Akoya Biosciences, Inc., Deep Bio, Inc., Evident Corporation, F. Hoffmann-La Roche Ltd., Ibex Medical Analytics Ltd., Indica Labs, Inc., Inspirata, Inc., LUMEA, Inc., MindPeak GmbH, Nucleai Inc., OptraSCAN Inc., Paige.AI, Inc., PathAI, Inc., Proscia Inc., Techcyte, Inc., Tempus Labs, Inc., Tribun Health, Visikol, Inc. by CELLINK, and Visiopharm A/S.

Market Segmentation & Coverage

This research report categorizes the AI in Pathology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Component, market is studied across Hardware and Software.
  • Based on Neural Network, market is studied across Convolutional neural networks (CNNs), Generative adversarial networks (GANs), and Recurrent neural networks (RNNs).
  • Based on Application, market is studied across Clinical Workflow, Disease Diagnosis & Prognosis, Drug Discovery, and Training & Education.
  • Based on End-User, market is studied across Academic & Research Institutes, Hospitals, and Pharmaceuticals & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing digitalization of pathology worldwide
      • 5.1.1.2. Growing need for telepathology with the prevalence of chronic disease
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with AI in pathology
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in AI in pathology
      • 5.1.3.2. Rising demand for personalized and customized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with data privacy
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: Extensive software applications in pathology for seamless workflows and efficient data management
    • 5.2.2. Neural Network: Increasing generative adversarial networks adoption due to diagnostic accuracy and efficiency
    • 5.2.3. Application: Wide utilization of AI in pathology for disease diagnosis to facilitate early detection of diseases
    • 5.2.4. End-User: Expansion of pathology AI in pharmaceuticals & biotechnology companies for discovering potential therapeutics
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. AI in Pathology Market, by Component

  • 6.1. Introduction
  • 6.2. Hardware
  • 6.3. Software

7. AI in Pathology Market, by Neural Network

  • 7.1. Introduction
  • 7.2. Convolutional neural networks (CNNs)
  • 7.3. Generative adversarial networks (GANs)
  • 7.4. Recurrent neural networks (RNNs)

8. AI in Pathology Market, by Application

  • 8.1. Introduction
  • 8.2. Clinical Workflow
  • 8.3. Disease Diagnosis & Prognosis
  • 8.4. Drug Discovery
  • 8.5. Training & Education

9. AI in Pathology Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Hospitals
  • 9.4. Pharmaceuticals & Biotechnology Companies

10. Americas AI in Pathology Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific AI in Pathology Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa AI in Pathology Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Microsoft Collab to Build World's Largest Pathology, Oncology Imaging AI
    • 13.3.2. PathAI Announces PathExplore, an AI-powered Pathology Panel to Unlock Untapped Insights from the Tumor Microenvironment
    • 13.3.3. Paige and Leica Biosystems Announce Expanded Partnership to Enhance Use of Image Management and Artificial Intelligence Technology in Global Digital Pathology Workflows
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. aetherAI
  • 2. Aiforia Technologies Oyj
  • 3. Akoya Biosciences, Inc.
  • 4. Deep Bio, Inc.
  • 5. Evident Corporation
  • 6. F. Hoffmann-La Roche Ltd.
  • 7. Ibex Medical Analytics Ltd.
  • 8. Indica Labs, Inc.
  • 9. Inspirata, Inc.
  • 10. LUMEA, Inc.
  • 11. MindPeak GmbH
  • 12. Nucleai Inc.
  • 13. OptraSCAN Inc.
  • 14. Paige.AI, Inc.
  • 15. PathAI, Inc.
  • 16. Proscia Inc.
  • 17. Techcyte, Inc.
  • 18. Tempus Labs, Inc.
  • 19. Tribun Health
  • 20. Visikol, Inc. by CELLINK
  • 21. Visiopharm A/S